Abstract
Human cellular prion protein (PrPC) is involved in several neurodegenerative disorders; however, its normal function is unknown. We report here that a synthetic peptide corresponding to the four-octarepeat sequence of the PrPC (PrP59–91) protects hippocampal neurons against copper neurotoxic effects in vivo. Using a rat bilateral intrahippocampal injection model, we found that PrP59–91 protects against copper-induced neurotoxicity, including a recovery in spatial learning performance and a reduced neuronal cell loss and astrogliosis. Previous studies from our laboratory indicated that a tryptophan (Trp) residue plays a key role in the reduction of copper(II) to copper(I); therefore several PrP59–91 fragments lacking histidine (His) and Trp residues were tested for their capacity to protect from copper toxicity. A PrP59–91 peptide lacking His residue shows as much neuroprotection as the native peptide; however, PrP59–91 without Trp residues only partially protected against copper toxicity. The neuroprotective effect not only occurs with PrP59–91, in fact a full neuroprotection was also observed using just one octamer of the N-terminal region of prion protein. We conclude that the N-terminal tandem octarepeat of the human PrPC protects neurons against copper toxicity by a differential contribution of the binding (His) and reducing (Trp) copper activities of PrP59–91. Our results are consistent with the idea that PrPC function is related to copper homeostasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370: 295–297.
Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996; 380: 639–642.
Tobler I, Deboer T, Fischer M . Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 1997; 17: 1869–1879.
Ruiz FH, Silva E, Inestrosa NC . The N-terminal tandem repeat region of human prion protein reduces copper: role of tryptophan residues. Biochem Biophys Res Commun 2000; 269: 491–495.
Brown DR . Copper and prion disease. Brain Res Bull 2001; 55: 165–173.
Opazo C, Barría MI, Ruiz F, Inestrosa NC . Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. Biometals 2003; 16: 91–98.
Hartmann HA, Evenson MA . Deficiency of copper can cause neuronal degeneration. Med Hypotheses 1992; 38: 75–85.
Sparaco M, Hirano A, Hirano M, DiMauro S, Bonilla E . Cytochrome c oxidase deficiency and neuronal involvement in Menkes' kinky hair disease: immunohistochemical study. Brain Pathol 1993; 3: 349–354.
Menkes JH . Kinky hair disease: twenty five years later. Brain Dev 1988; 10: 77–79.
Brown DR, Wong BS, Hafiz F, Clive C, Haswell SJ, Jones IM . Normal prion protein has an activity like that of superoxide dismutase. Biochem J 1999; 15(344 Part 1): 1–5.
Pattison IH, Jebbett JN . Clinical and histological observations between cuprizone toxicity and scrapie in mice. Res Vet Sci 1071; 12: 378–380.
Kimberlin RH, Millson GC, Bountiff L, Collis SC . A comparison of the biochemical changes induced in mouse brain by cuprizone toxicity and by scrapie infection. J Comp Pathol 1974; 84: 263–270.
Brown DR, Qin K, Herms JW, Madlung A, Jean M, Strome R et al. The cellular prion protein binds copper in vivo. Nature 1997; 390: 684–687.
Stöckel J, Safar J, Wallace AC, Cohen FE, Prusiner S . Prion protein selectively binds copper(II) atoms. Biochemistry 1998; 37: 7185–7193.
Viles JH, Cohen FE, Prusiner SB, Goodin DB, Wright PE, Dyson HJ . Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci USA 1999; 96: 2042–2047.
Jackson GS, Murray I, Hosszu LLP, Gibbs N, Waltho JP, Clarke AR et al. Location and properties of metal-binding sites on the human prion protein. Proc Nat Acad Sci USA 2001; 98: 8531–8535.
Kramer ML, Kratzin HD, Schmidt B, Römer A, Wind O, Liemann S et al. Prion protein binds copper within the physiological concentration range. J Biol Chem 2001; 276: 16711–16719.
Burns CS, Aronoff-Spencer E, Dunham CM, Lario P, Avdievich NI, Antholine WE et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 2002; 41: 3991–4001.
Pauly PC, Harris DA . Copper stimulates endocytosis of the prion protein. J Biol Chem 1998; 273: 33107–33110.
Sumudhu W, Perera S, Hooper NM . Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol 2001; 11: 519–523.
Chacón M, Barría MI, Inestrosa NC . Neuroprotective properties of copper binding fragments of APP and PrP against copper toxicity. Neurobiol Aging 2002; 23(Suppl 1): S26.
Morris RGM . Development of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47–60.
Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates, 2 ed. Academic Press: New York, 1986.
Côté SL, Ribeiro-Da-Silva A, Cuello AC In Cuello AC (ed). Immunocytochemistry II, John Wiley & Sons: New York, 1993.
Hartter DE, Barnea A . Brain tissue accumulates 67Cu by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process. J Biol Chem 1988; 263: 799–805.
Lorca RA, Chacón M, Barría MI, Inestrosa NC, Huidobro-Toro JP . The human prion octarepeat fragment prevents and reverses the inhibitory action of copper in the P2X4 receptor without modifying the zinc action. J Neurochem 2003; 85: 709–716.
Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21: 3307–3316.
Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R . Cellular prion protein transduces neuroprotective signals. EMBO J 2002; 21: 3317–3326.
Zeng F, Watt NT, Walmsley AR, Hooper NM . Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J Neurochem 2003; 84: 480–490.
Rachidi W, Vilette D, Guiraud O, Arlotto M, Riondel J, Laude H et al. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 2003; 278: 9064–9072.
Garnett AP, Viles JH . Copper binding to the octarepeats of the prion protein. Affinity, specificity, folding, and cooperativity; insights from circular dichroism. J Biol Chem 2003; 278: 6795–6802.
Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH . Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 1991; 88: 11158–11162.
Chan PH . Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1124–1129.
Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 1997; 17: 4180–4189.
Acknowledgements
This work was supported by the International Copper Association (ICA, New York, NY), FONDAP-Biomedicine Grant No. 13980001 and the Millennium Institute of Fundamental and Applied Biology (MIFAB).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chacón, M., Barría, M., Lorca, R. et al. A human prion protein peptide (PrP59–91) protects against copper neurotoxicity. Mol Psychiatry 8, 853–862 (2003). https://doi.org/10.1038/sj.mp.4001400
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001400
Keywords
This article is cited by
-
Vacuolar degeneration affecting brain macrophages/microglia in variant CJD: a report on two cases
Acta Neuropathologica (2007)